Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs ethamsylate (control)
Withdrawals due to adverse events · women with heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes withdrawal from treatment because of adverse events compared with ethamsylate (very low certainty).
1 finding from 1 review
- RR 0.78 [0.19, 3.15]1 study · 53 participantsVery low